Clinical Trials Browser

Terminated × Has results × motexafin gadolinium × Clear all

NCT00089284 2019-08-14

Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL

Phase 1/2 Terminated

30 enrolled 12 charts

Lymphoma, Non-Hodgkin